Abstract:N-6-methyladenosine (m(6)A) is the most prevalent internal messenger RNA (mRNA) chemical modification in eukaryotes. This methylation has been shown to be reversible in mammals. It is installed by a methyltransferase complex (writers) of METTL3, METTL14, and Wilms' tumor 1-associating protein (WTAP) and can be removed by demethylases (erasers) FTO and ALKBH5, which are iron(II)- and a-ketoglutarate-dependent dioxygenases. The reversible and dynamic methylation exhibits significant functional roles in various biological processes. The m(6)A modification as an RNA mark is recognized by reader proteins, such as YTH domain family proteins. YTHDF2 regulates the stability of the methylated transcripts in cytoplasm; YTHDF1 promotes protein synthesis of the methylated mRNA by interacting with translation machinery. m(6)A as a switch controls the RNA structure to affect RNA-protein interactions for biological regulation. Meanwhile, many m(6)A detection techniques were developed and applied in biology and medicine. The total m(6)A level in mRNA can be determined by ultra-performance liquid chromatography coupled with triple-quadrupole tandem mass spectrometry (UPLC-QQQ-MS/MS), two-dimensional thin-layer chromatography (2-D TLC), and dot blot. The m(6)A antibody affinity sequencing (MeRIP-seq) was developed to map the m(6)A site location in a transcriptome-wide manner. The single-base resolution methods for single gene or whole transcripts were also invented.

Cap-specific terminal N 6-methylation of RNA by an RNA polymerase II-associated methyltransferase

The cap-specific m6A methyltransferase, PCIF1/CAPAM, is dynamically recruited to the gene promoter in a transcription-dependent manner

Enzymatic characterization of mRNA cap adenosine-N6 methyltransferase PCIF1 activity on uncapped RNAs

Rna N-6-Methyladenosine Methylation In Post-Transcriptional Gene Expression Regulation

Cap-specific Terminal N6-methyladeonsine Methylation of RNA Mediated by PCIF1 and Possible Therapeutic Implications

Cap-Specific m6Am Methyltransferase PCIF1/CAPAM Regulates mRNA Stability of RAB23 and CNOT6 through the m6A Methyltransferase Activity

A METTL3–METTL14 Complex Mediates Mammalian Nuclear RNA N 6 -Adenosine Methylation

Targeted Manipulation of Cellular RNA m6A Methylation at theSingle-Base Level br

The Mammalian Cap-Specific m6Am RNA Methyltransferase PCIF1 Regulates Transcript Levels in Mouse Tissues

Cryo-EM Structures of Human M6a Writer Complexes

Preparation of Human Nuclear RNA m⁶A Methyltransferases and Demethylases and Biochemical Characterization of Their Catalytic Activity.

CAPAM: The mRNA Cap Adenosine N6-Methyltransferase

PCIF1 Catalyzes m6Am mRNA Methylation to Regulate Gene Expression

Identification of the m6Am Methyltransferase PCIF1 Reveals the Location and Functions of m6Am in the Transcriptome

Rna Modification N-6-Methyladenosine in Post-Transcriptional Regulation

PCIF1, the only methyltransferase of N6,2-O-dimethyladenosine

The identity and methylation status of the first transcribed nucleotide in eukaryotic mRNA 5′ cap modulates protein expression in living cells

Structural and Functional Characterization of the Proteins Responsible for N(6)-Methyladenosine Modification and Recognition.

Trinucleotide mRNA Cap Analogue N 6-Benzylated at the Site of Posttranscriptional m6 A m Mark Facilitates mRNA Purification and Confers Superior Translational Properties In Vitro and In Vivo

RNA m6A methylation across the transcriptome

Structural Insights into N 6 -Methyladenosine (m 6 A) Modification in the Transcriptome